Evaluation of a Point of Care Test for hCG in blood
Research type
Research Study
Full title
The Evaluation of a Point of Care Device for the Analysis of Beta-Human Chorionic Gonadotrophin in Whole Blood
IRAS ID
128414
Contact name
Ian Smith
Contact email
Sponsor organisation
Oxford University Hospitals NHS Trust
Research summary
Point of Care Analyzers are devices that will perform a diagnostic test close to the patient. They remove the requirement to send a specimen (generally blood or urine) to the laboratory.
These analyzers produce results much quicker than the traditional laboratory methods, which require the specimen to be transported to the laboratory before testing.Beta-Human Gonadotrophin is a hormone produced by the fertilized egg after conception. Later during pregnancy it is made by the developing placenta. It is therefore widely used to monitor the progression of pregnancy.
The aim of the project is to compare the performance of a new point of care method for testing hCG using a specific test cartridge in the Abbott i-Stat analyser, to the standard laboratory method (the Siemens Centaur)and also another method that is used in the the lab, the Perkinelmer AutoDelfia in order to ascertain if the performance is consistent.
REC name
West Midlands - Coventry & Warwickshire Research Ethics Committee
REC reference
13/WM/0492
Date of REC Opinion
29 Nov 2013
REC opinion
Favourable Opinion